Home
Search
Study Topics
Glossary
|
Study 11 of 8894 for search of: | United States, Texas |
Previous Study | Return to Search Results | Next Study |
|
|
|
|
|
Sponsored by: |
ALTANA Pharma |
---|---|
Information provided by: | ALTANA Pharma |
ClinicalTrials.gov Identifier: | NCT00163501 |
The purpose of this study is to investigate the safety and effectiveness of ciclesonide nasal spray as compared with placebo (inactive substance) nasal spray in relieving symptoms of perennial allergic rhinitis.
Condition | Intervention | Phase |
---|---|---|
Perennial Allergic Rhinitis Allergic Rhinitis Hay Fever |
Drug: Ciclesonide |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Single Group Assignment |
Official Title: | A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Clinical Trial to Assess the Long Term Safety of Ciclesonide, Applied as a Nasal Spray (200 Mcg, Once Daily) in the Treatment of Perennial Allergic Rhinitis (PAR) in Patients 12 Years and Older |
Ages Eligible for Study: | 12 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Main Inclusion Criteria:
Main Exclusion Criteria:
Study Chair: | Mark A. Wingertzahn, Ph.D. | Altana Pharma, Florham Park, NJ 07932, USA |
Study ID Numbers: | BY9010/M1-404 |
Study First Received: | September 12, 2005 |
Last Updated: | July 16, 2008 |
ClinicalTrials.gov Identifier: | NCT00163501 |
Health Authority: | United States: Food and Drug Administration |
Allergy Perennial Allergic Rhinitis Allergic Rhinitis Hay Fever |
Fever Hypersensitivity Otorhinolaryngologic Diseases Respiratory Tract Infections Respiratory Tract Diseases Rhinitis, Allergic, Perennial |
Ciclesonide Rhinitis, Allergic, Seasonal Hypersensitivity, Immediate Rhinitis Respiratory Hypersensitivity |
Immune System Diseases Therapeutic Uses Anti-Allergic Agents Pharmacologic Actions Nose Diseases |